
Waters Unveils Xevo TQ Absolute XR for Clinical Diagnostics
With a fivefold increase in sensitivity over existing clinical instruments, Waters Corporation has launched the Xevo TQ Absolute XR IVD Mass Spectrometer. Unveiled at the 2026 ADLM Annual Meeting, the system aims to improve diagnostic accuracy for complex biological matrices in women’s health, oncology, and forensic toxicology.






















:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2212073679-35f87660f5a64ff5962b11364b4f5e09.jpg)

